Home / Al-Razi Medical Co. / 2024 Annual Results

Al-Razi Medical Co. 2024 Annual Results

Revenue

SAR 61M

Net Profit

SAR 176K

EPS

SAR 0.12

Operating Cash Flow

SAR 5M

Al-Razi Medical Co. (9572) reported full year 2024 revenue of SAR 61M, up 0.0% from SAR 61M in 2023. Net profit came in at SAR 176K, down 74.4% year on year. Earnings per share were SAR 0.12. The company generated SAR 5M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 28.19 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 28.19.

Key Financial Metrics

Metric	2024	2023
Revenue	SAR 61M	SAR 61M
Net Profit	SAR 176K	SAR 686K
Net Margin	0.3%	1.1%
ROE	0.8%	3.1%
EPS	SAR 0.12	SAR 0.45
Total Assets	SAR 41M	SAR 45M
Total Equity	SAR 23M	SAR 22M
Total Liabilities	SAR 18M	SAR 23M
Operating Cash Flow	SAR 5M	SAR 6M

Year on Year Comparison

Revenue increased by 0.0% compared to 2023. Net profit decreased by 74.4%. Revenue grew but profit declined — suggesting margin pressure.

View full company profile →

View all years:

2024 2023

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2025-08-11.